NGM Biopharmaceuticals Obtains $51,000,000 Series B Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed7bae3b-3c45-4427-bad6-d9b8b1b7c06f&Preview=1 - Date
3/15/2010 - Company Name
NGM Biopharmaceuticals - Mailing Address
630 Gateway Blvd South San Francisco, CA 94080-7014 - Company Description
The company is focused on developing treatments for metabolic diseases. - Website
http://www.ngmbio.com - Transaction Type
Venture Equity - Transaction Amount
$51,000,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
The Column Group - Venture Investor
Tichenor Ventures - Venture Investor
Prospect Venture Partners - Venture Investor
Rho Ventures
